Tensinumab

N/A

Report date: 2022/12/19 14:47:32

Base Information

Drug NameTensinumab
Drug Alias NameATN-E11ATN-E-11
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAngiotensin II Receptor Type 1 modulators
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesATen Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesATen Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A